Strata Critical Medical, Inc. Class A Common Stock (SRTA) Q1 2024 Earnings
Strata Critical Medical, Inc. Class A Common Stock reported Q1 2024 revenue of $51.5M, beat analyst consensus of $49.5M by $2.1M. Diluted EPS came in at $-0.06, beat the $-0.13 consensus by $0.07.
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Strata Critical Medical, Inc. Class A Common Stock's Q1 2024 earnings report.
Strata Critical Medical, Inc. Class A Common Stock (SRTA) reported Q1 2024 earnings on May 7, 2024 before market open.
Strata Critical Medical, Inc. Class A Common Stock reported revenue of $51.5M and diluted EPS of $-0.06 for Q1 2024.
Revenue beat the consensus estimate of $49.5M by $2.1M. EPS beat the consensus estimate of $-0.13 by $0.07.
You can read the 10-Q periodic report (0001779128-24-000068) directly on SEC EDGAR. The filing index links above go to sec.gov.